AstraZeneca Pharmaceuticals LP
2871 articles about AstraZeneca Pharmaceuticals LP
-
AstraZeneca PLC Submits an sNDA for SYMBICORT(R) for COPD Indication
4/30/2008
-
Synexus' AstraZeneca PLC's Crestor Jupiter Study Stopped Early
4/18/2008
-
Washington University in St. Louis and AstraZeneca PLC Announce Alzheimer's Research Collaboration
4/17/2008
-
AstraZeneca PLC Soars on Nexium Drug Patent Settlement
4/15/2008
-
AstraZeneca PLC Netherlands Chooses TIBCO Spotfire for Sales & Marketing Business Intelligence
4/7/2008
-
China a Priority for AstraZeneca PLC
3/20/2008
-
Cenix BioScience GmbH Signs Framework Research Agreement with AstraZeneca PLC for RNAi-Based Drug Discovery
3/19/2008
-
AstraZeneca PLC Study Compares Bronchodilatory Effects of SYMBICORT(R) and Advair in Adults With Asthma
3/18/2008
-
AstraZeneca PLC Study Analyzed Long-Term SYMBICORT(R) Use in Children With Persistent Asthma SYMBICORT Was Well Tolerated in 26-Week Study
3/17/2008
-
Silence Therapeutics plc and AstraZeneca PLC Announce Collaboration to Develop Novel Approaches for siRNA Drug Delivery
3/13/2008
-
AstraZeneca PLC Completes Enrollment in Two Pivotal Phase III Studies of the Investigational Drug Vandetanib (ZACTIMA(R)) in Non-Small Cell Lung Cancer (NSCLC)
3/12/2008
-
Cognizant Signs $95M Services Pact with AstraZeneca PLC
3/11/2008
-
AstraZeneca PLC Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder
2/29/2008
-
Merck & Co., Inc. Keeps Rights to Certain AstraZeneca PLC Drugs
2/28/2008
-
FDA Approves AstraZeneca PLC's NEXIUM(R) for the Treatment of Short-Term GERD in Children 1 to 11 Years Old
2/28/2008
-
AstraZeneca PLC's Recentin Fails Lung Cancer Trial
2/27/2008
-
AstraZeneca PLC Response to February 21, 2008 Ruling
2/22/2008
-
AstraZeneca PLC Spins Out Albireo
2/14/2008
-
Cell Signaling Technology, Inc. Announces Continued Collaboration with AstraZeneca PLC to Provide CST's PhosphoScan(R) Platform for Kinase Inhibitor Proteomic Profiling
2/12/2008
-
Meditrina Pharmaceuticals, Inc. Announces Exclusive Global License Agreement With AstraZeneca PLC
2/6/2008